Skip to main content

You can now buy a laptop with NVIDIA's RTX SUPER graphics cards

NVIDIA's RTX SUPER graphics cards feature updated Max-Q dynamic scaling technology for better efficiency.What you need to knowNVIDIA is debuting RTX SUPER graphics cards on laptops.The cards feature new Max-Q optimizations for eking out more efficiency while delivering better performance at the same time.RTX 2060-powered designs are available at $999 from ASUS, Acer, MSI, HP, and more.NVIDIA is introducing its RTX SUPER graphics cards on laptops for the first time, with the GeForce RTX 2080 SUPER and 2070 SUPER now available for customization. Over 100 designs powered by the RTX 2080 SUPER, RTX 2070 SUPER, and the RTX 2060 will be available from NVIDIA's global partners starting from the week of April 15.RTX SUPER graphics cards feature dedicated RT cores for real-time ray tracing, and NVIDIA is also touting significant enhancements to its Max-Q technology. As a refresher, Max-Q allows NVIDIA's partners to deliver the latest video cards in thin and lightweight designs, wit…

How one company is fast-tracking development of potential plasma-based treatments for the coronavirus

Medical biotech company Emergent BioSolutions is one of the many health industry players turning its efforts toward addressing the current global coronavirus pandemic. Their work includes a two-pronged effort to pursue plasma-based treatments that could help lessen the impact of COVID-19 on healthcare systems, with a fast-tracked development timeline that could see human clinical trials start as soon as this summer.

The company is simultaneously working on two different therapeutic approaches, including one that uses plasma (a liquid that is the majority component of blood) sourced from humans, and one that sources it from horses. Both involve development of antibodies consisting of different immune cells that all target the SARS-CoV-2 virus, which work by boosting the body’s existing immune response in patients to fight off infection. The treatment based on human plasma would be suitable for use for patients who are hospitalized and showing severe symptoms, and also potentially for providing some measure of protection for at-risk people, including front-line healthcare workers, while the horse-derived version would be aimed specifically at addressing those severe hospitalized cases.

Plasma-based treatments (which involve purifying out the antibodies and concentrating the dose) are not new, and both of these therapies in development will leverage technologies, manufacturing processes and other infrastructure that Emergent BioSolutions has used in developing other FDA-approved plasma-based treatments for different diseases. That’s what’s helping it fast-track its work on solutions to address COVID-19, which could bridge the gap between where we are now and the year or more it will take to develop an effective vaccine.

“We looked at where we are in our platforms, and our ability to take some of our proven technologies and apply it to COVID-19,” explained Dr. Laura Saward, head of Emergent BioSolution’s Therapeutics Business Unit. “On the therapeutic side, there were two areas we were really focused on. I think the opportunity to provide a therapy that would be a rescue therapy for patients in hospital, who are suffering from severe disease is definitely a need today, as well as the ability to go in and prevent people at risk from developing more severe disease.”

The goal, with both approaches, Dr. Saward said, is to attempt to reduce the burden suffered by the healthcare system, freeing up its resources to better address the coronavirus crisis. That’s a similar end to the strategy of encouraging individuals to distance themselves physically from one another — health officials are hoping that, if these rules are properly observed, individuals can avoid being infected all at once and overwhelming the hospital system.

Therapeutics used in treatment of cases could be another key ingredient in a larger plan designed to mitigate the most dire projected effects of a global coronavirus pandemic. Especially when, as is the case with the treatments that Emergent BioSolutions is developing, there is already infrastructure in place that can help speed the development of these therapeutics.

“We have two platforms that we looked at, within the antibody therapeutics space, really looking at our existing infrastructure, and the manufacturing processes that we have as part of our overall platform for this approach,” Dr. Saward said. “You know, in the, in this situation, when we looked at these two platforms, they supported several FDA-licensed drugs, which, while it doesn’t give us the benefit of having some sense of dosing safety, we can certainly use that manufacturing process in a way where we’ve got our our common elements for manufacturing and controls and would help to support an FDA application.”

There has been plenty said about efforts by the FDA and other global health agencies to cut through red tape and speed the approval process around COVID-19. That includes everything from tests to treatments and vaccines. I asked Dr. Saward what’s actually involved in fast-tracking something as sensitive and safety focused as approval for new therapeutics.

“We’ve always worked very closely with the regulators in understanding sort of what parts of those packages are common to our process,” she said. “As we bring a new drug through, we’re often able to leverage many of the same elements around the safety profile, the PK profile [basically how fast a drug is absorbed, metabolized, excreted, etc.] for the products, the manufacturing controls and assays that are validated — that’s all common. What we’re changing, really, is just at the front end: The plasma that’s going into that process will be specific to the COVID antibodies in this case.”

This ensures that while they can still ensure safety, they don’t need to do re-work that would otherwise be time-consuming for processes into which the FDA already has full visibility. Time and effort can focus on the stages of the drug development that are new, instead of on what’s repeated.

Thanks to its ability to leverage past work, Emergent BioSolutions is now working with a time frame that includes entering manufacturing by this summer, and then having products available in test clinics by end of summer. If all goes to plan, that means kicking off Phase Two testing in human patients by around late summer or early fall.

That may seem a long way off, but it’s actually a speedy timeline by therapeutics development standards. Saward says that she’s seen the FDA evolve their thinking on data collection and dynamism in light of technological advancement, which has helped their collaboration with industry in getting needed treatments to market. In the meantime, that still means individuals need to do their part to provide Emergent and others working on these solutions the time they need for proper development and testing, through actions like physical distancing and self-isolation.



Source: https://tcrn.ch/3amGcjl
1 / 4
2 / 4
3 / 4
4 / 4

Popular posts from this blog

Fortnite Battle Royale Apk Download And Install (iOS And Android)

Fortnite Battle Royale Game has officially announced for both iOS and Android devices. But you’re obviously wondering how you can play Fortnite Battle Royale game on your iPhone, iPad. This fortnite apk first was released for Apple’s devices. But later it has been released for all over the devices except Pc/Desktop And Laptops.

Although, Fortnite apk game is only accessible by user invitation or you need the fortnite invite code. So if you really want to play the fortnite apk, so you must go to their official website and create an account as a beta tester for the ios version of the fortnite mobile app.

You can also use your mobile to sign up an account. But you must have at least an iPhone 6 or higher. Even, you can invite your friends by sending them an invitation code.

Related: Fortnite - Deluxe Founder's Pack - Xbox One [Digital Code]- ITS GREAT BECAUSE IT GIVES YOU A CODE THAT YOU CAN USE TO DO MORE STUFF LIKE SAVE THE WORLD AND OTHER STUFF.

How To Download Fortnite Apk?

How to watch the Felder vs. Hooker UFC Fight Night 168 live stream online

This Saturday, February 22, Dan Hooker and Paul Felder will step into the octagon together in the lightweight bout of the evening. Weighing in at 155 pounds, the two have similar records to date, though Hooker is a bit taller with a longer reach which could prove favorable during the fight.

Paul Felder has a 16-4-0 record to date, while Dan Hooker sits at 19-8-0. The two have similar KO/TKO stats, though Felder is used to a longer fight, with his average time sitting just over three minutes more than Hooker's. The fight takes place in Auckland, New Zealand this time around, and streams exclusively on ESPN+ in the U.S.



You'll want to make sure you check out all the details below so that you are prepared to tune in when the fight begins instead of scrambling to set your accounts up.
UFC Fight Night 168: When & whereUFC Fight Night 168 takes place on Saturday, February 22. The event will be broadcasted live from the Spark Arean in Auckland, New Zealand. Prelims will start at 4…

Google collects face data now. Here's what it means and how to opt out

Google's new Face Match technology isn't everywhere yet, but it's always looking. Find out what's happening with your face data and what you can do stop it.

Google's latest smart display brings with it a controversial new feature that's always watching. Face Match, introduced on the Google Nest Hub Max, uses the smart display's front-facing camera as a security feature and a way to participate in video calls. It also shows you your photos, texts, calendar details and so on when it recognizes your face.
This mode of facial recognition sounds simple enough at first. But the way companies like Google collect, store and process face data has become a top concern for privacy-minded consumers. Plenty of people want to know who has their personal information once it makes its way into the cloud.

Here's a look at how Google and other tech companies record, save, process and use facial recognition data collected by devices such as the Nest Hub Max, as well as s…

iPhone 11 and iPhone 11 Pro Design, Camera, Specs and Pricing

Today, Apple has unveiled a new set of phones, including the iPhone 11, the iPhone 11 Pro and the iPhone 11 Pro Max. These new devices are powered by a new chip, sport new cameras and are available in a variety of finishes and sizes.

So without any further ado, let’s get into some of the details.

How to bring Harry Potter magic to your Facebook account

Quickly, Potterheads, to Facebook!
Wanna feel old? The first Harry Potter book was released 20 years ago today. Don't let that bum you out, though. In celebration of this anniversary, Facebook has turned a few of your favorite words into spells you and your friends can activate on both the app and the website.

Here's how it works!

Casting a Harry Potter spell on Facebook


iPhone Feature Request: Copy ‘Skip Lock Screen’ feature from Google’s Pixel 4

Face Unlock on Google’s Pixel 4 is less secure than the iPhone’s Face ID, but it does have one feature I’d like to see Apple copy: Skip Lock Screen.

Copying that would be perfectly fair, as Google has recently confirmed that it will be copying at least part of Face ID’s Require Attention feature…


The Pixel 4 will copy Require AttentionLike Apple’s iPhone X, XS, and 11, Google’s new flagship Pixel 4 smartphone can unlock by recognizing your face. However, the company quickly came under fire when it was revealed that the device can be unlocked even when the owner is asleep, simply by someone else holding it up to their face.

With iPhones, there is a Requires Attention toggle. When this is on, your iPhone will only unlock if your eyes are open and you are actually looking at the screen. Google has now said that it plans to copy at least the first part of this requirement.

Google this evening confirmed to The Verge that it’s “been working on an option for users to require their eyes to be ope…

Download and install WhatsApp on PC (Windows 7.8) using YouWave

WhatsApp is an instant messaging application for smartphone users to use based on data provided by the network operator services. Therefore messaging via WhatsApp does not cost any office network and instead only data costs are charged to almost nothing. In simple words, WhatsApp uses the Internet to allow communication between users, compared to an SMS-based service network.

WhatsApp is the brainchild of two former employees of Yahoo that WhatsApp Inc. founded in 2009. It was founded by Brian Acton and Jan Koum, who based his company in Mountain View, California. WhatsApp is now so popular that it has 700 million active users per day, compared with 830 million users are active on Facebook. Sensing a possible threat of WhatsApp, people began to prefer Facebook, when it was based communication network, Facebook decided to acquire WhatsApp in 2014 by a whopping amount of fat acquisition of $ 19,000,000,000.

Although there have been sporadic reports about a possible release of the PC ve…